FR12C0073I2 - Vaccin aviaire contre e. coli destine a la protection contre la colibacillose - Google Patents

Vaccin aviaire contre e. coli destine a la protection contre la colibacillose

Info

Publication number
FR12C0073I2
FR12C0073I2 FR12C0073C FR12C0073C FR12C0073I2 FR 12C0073 I2 FR12C0073 I2 FR 12C0073I2 FR 12C0073 C FR12C0073 C FR 12C0073C FR 12C0073 C FR12C0073 C FR 12C0073C FR 12C0073 I2 FR12C0073 I2 FR 12C0073I2
Authority
FR
France
Prior art keywords
coli
colibacillosis
avian vaccine
protection against
protection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR12C0073C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of FR12C0073I1 publication Critical patent/FR12C0073I1/fr
Application granted granted Critical
Publication of FR12C0073I2 publication Critical patent/FR12C0073I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR12C0073C 2003-05-14 2012-12-10 Vaccin aviaire contre e. coli destine a la protection contre la colibacillose Active FR12C0073I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47047103P 2003-05-14 2003-05-14

Publications (2)

Publication Number Publication Date
FR12C0073I1 FR12C0073I1 (xx) 2013-01-18
FR12C0073I2 true FR12C0073I2 (fr) 2013-08-16

Family

ID=33476714

Family Applications (1)

Application Number Title Priority Date Filing Date
FR12C0073C Active FR12C0073I2 (fr) 2003-05-14 2012-12-10 Vaccin aviaire contre e. coli destine a la protection contre la colibacillose

Country Status (28)

Country Link
US (2) US7357935B2 (xx)
EP (1) EP1622642B1 (xx)
JP (2) JP5334029B2 (xx)
KR (1) KR101106024B1 (xx)
CN (1) CN100387299C (xx)
AR (1) AR044338A1 (xx)
AT (1) ATE380557T1 (xx)
AU (1) AU2004240584B2 (xx)
BE (1) BE2012C053I2 (xx)
BR (1) BRPI0410332B1 (xx)
CA (1) CA2524942C (xx)
CO (1) CO5640040A2 (xx)
CY (1) CY1107188T1 (xx)
DE (1) DE602004010643T2 (xx)
DK (1) DK1622642T3 (xx)
ES (1) ES2297448T3 (xx)
FR (1) FR12C0073I2 (xx)
HK (1) HK1083597A1 (xx)
HR (1) HRP20080069T3 (xx)
HU (1) HUS1200029I1 (xx)
MX (1) MXPA05012218A (xx)
NZ (1) NZ543559A (xx)
PL (1) PL1622642T3 (xx)
PT (1) PT1622642E (xx)
SI (1) SI1622642T1 (xx)
TW (1) TW200505475A (xx)
WO (1) WO2004103402A1 (xx)
ZA (1) ZA200509979B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297338B2 (en) * 2003-05-14 2007-11-20 Wyeth Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella
CN101575586B (zh) * 2009-05-31 2011-01-19 华中农业大学 一种支气管败血波氏杆菌基因缺失疫苗及应用
KR101321501B1 (ko) * 2011-09-21 2013-10-29 주식회사 바이오포아 조류 대장균증 백신 조성물 및 이의 제조방법
BRPI1105176A2 (pt) * 2011-11-22 2013-09-10 Unicamp linhagens de escherichia coli, atenuadas para septicemia em aves, vacinas produzidas com essas linhagensm, metodo de produÇço de vacinas e seus usos
US9814769B2 (en) 2014-09-30 2017-11-14 Qatar University Vaccines against pathogenic Escherichia coli and methods of using the same
CN106465698A (zh) * 2016-09-24 2017-03-01 王德 一种预防雏鸡大肠杆菌病的方法
CN106987549B (zh) * 2017-04-26 2020-08-21 河北科星药业有限公司 培养基及相应的预防禽类大肠杆菌病的广谱菌苗的生产方法
KR20190070457A (ko) 2017-12-13 2019-06-21 주식회사 오투파워 이산화염소를 포함하는 닭 대장균증 예방을 위한 음용수 첨가용 조성물
CN112442473B (zh) * 2020-12-02 2022-10-25 青岛易邦生物工程有限公司 一种禽大肠杆菌疫苗株
CN112494641B (zh) * 2020-12-02 2022-07-05 青岛易邦生物工程有限公司 一种禽大肠杆菌活疫苗
CN112695004A (zh) * 2020-12-28 2021-04-23 南通大学 APEC双基因rpoS和arcA缺失菌株及弱毒疫苗
EP4252770A1 (en) 2022-04-01 2023-10-04 Veterinärmedizinische Universität Wien Composition comprising irradiated e. coli
CN116024151B (zh) * 2022-12-13 2024-01-26 南通大学 一种禽致病性大肠杆菌sRNA s078基因缺失菌株及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040958B1 (en) 1980-05-26 1984-03-14 Ici Australia Limited Process for the synthesis of gamma-unsaturated carboxylic acid esters
JPH085802B2 (ja) 1986-08-13 1996-01-24 日清製粉株式会社 家禽大腸菌症ワクチン
GB8912330D0 (en) 1989-05-30 1989-07-12 Wellcome Found Live vaccines
US5641491A (en) 1993-06-15 1997-06-24 The Penn State Research Foundation Escherichia coli strain 364 and use of said strain as a vaccine
JPH07206705A (ja) * 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
TR199902522T2 (xx) * 1997-04-11 2000-04-21 B. Of S.Visors Of Louisiana State Uni. & Agricul.& Bal�k patojenlerine kar�� zay�flat�lm�� invazif a��.
GB9806449D0 (en) * 1998-03-25 1998-05-27 Peptide Therapeutics Ltd Attenuated bacteria useful in vaccines
US7297338B2 (en) * 2003-05-14 2007-11-20 Wyeth Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella

Also Published As

Publication number Publication date
JP2011234721A (ja) 2011-11-24
US20080213317A1 (en) 2008-09-04
HUS1200029I1 (hu) 2017-02-21
AU2004240584A1 (en) 2004-12-02
CA2524942A1 (en) 2004-12-02
US20040234534A1 (en) 2004-11-25
US7575754B2 (en) 2009-08-18
CO5640040A2 (es) 2006-05-31
ZA200509979B (en) 2008-11-26
SI1622642T1 (sl) 2008-04-30
CA2524942C (en) 2012-10-23
CY1107188T1 (el) 2012-10-24
HRP20080069T3 (en) 2008-03-31
TW200505475A (en) 2005-02-16
KR20060012612A (ko) 2006-02-08
AR044338A1 (es) 2005-09-07
FR12C0073I1 (xx) 2013-01-18
PL1622642T3 (pl) 2008-03-31
DE602004010643T2 (de) 2008-12-04
JP5334029B2 (ja) 2013-11-06
JP2007500745A (ja) 2007-01-18
CN100387299C (zh) 2008-05-14
EP1622642B1 (en) 2007-12-12
CN1822855A (zh) 2006-08-23
BRPI0410332A (pt) 2006-05-30
BRPI0410332B1 (pt) 2019-10-08
EP1622642A1 (en) 2006-02-08
WO2004103402A1 (en) 2004-12-02
AU2004240584B2 (en) 2010-01-07
PT1622642E (pt) 2008-02-18
BE2012C053I2 (xx) 2023-08-09
DK1622642T3 (da) 2008-03-25
HK1083597A1 (en) 2006-07-07
MXPA05012218A (es) 2006-02-08
KR101106024B1 (ko) 2012-01-17
ATE380557T1 (de) 2007-12-15
DE602004010643D1 (de) 2008-01-24
NZ543559A (en) 2008-02-29
ES2297448T3 (es) 2008-05-01
US7357935B2 (en) 2008-04-15

Similar Documents

Publication Publication Date Title
FR12C0073I2 (fr) Vaccin aviaire contre e. coli destine a la protection contre la colibacillose
NO20053775D0 (no) Diazepinoindol derivater som kinaseinhibitorer.
DK2609947T3 (da) Plasterlignende infusionsapparat
NO20052149D0 (no) Vaksine.
DE602004023598D1 (de) Distale schutzvorrichtung
BR0318327B1 (pt) garra cirérgica.
NO20041699L (no) Beskyttelsesopplegg for rorledning.
DE602004014866D1 (de) Wärmedämmschicht
IS8325A (is) Bóluefni
ITFI20030199A1 (it) Valvola secondaria perfezionata per sommozzatore.
DK2233153T3 (da) Rotavirus-vaccine, som inducerer heterotypisk krydsbeskyttelse
NL1025908A1 (nl) Farmaceutische combinatie.
NO20053428D0 (no) Fremgangsmate for dermal beskyttelse.
ITRM20030053A0 (it) Associazione di farmaci antidiabetici.
ES1055675Y (es) Jeringa perfeccionada.
ITRM20050180A1 (it) Dispositivo regolabile per la protezione di serrature.
ITTV20030055A1 (it) Dispositivo di protezione per serrature a cilindro.
ES1051880Y (es) Protector para ceniceros.
ITRM20030308A1 (it) Repellente, antipuntura dopo puntura per zanzara.
ES1055633Y (es) Protector para calzado.
ES1056241Y (es) Soporte protector para plantas perfeccionado.
ITMO20020183A1 (it) Preparato per trattamenti di perdermostimolazione
ES1054264Y (es) Suela-plantilla, perfeccionada
ITVE20030054A1 (it) Catarifrangente per guardrail attivo.
ITRM20030163V0 (it) Protezione monouso per lavandini.